microfluidic organ-on-chip drug testing market Growth to Witness Great Development Analysis By FMI
NEWARK, DE | The Microfluidic Organ-on-Chip Drug Testing Market is poised for rapid expansion, rising from USD 141.5 million in 2025 to USD 932.9 million by 2036, advancing at a CAGR of 18.70%. With the market valued at USD 168.0 million in 2026, the shift toward human-relevant, predictive preclinical models is redefining drug development workflows and accelerating the replacement of...
0 Reacties 0 aandelen 9 Views 0 voorbeeld
Zepky https://zepky.com